-
LIPOSOMAL IRINOTECAN IN COMBINATION WITH OXALIPLATIN, 5-FLUOROURACIL AND LEUCOVORIN (NALIRIFOX) FOR THE FIRST-LINE TREATMENT OF ADULT PATIENTS WITH METASTATIC ADENOCARCINOMA OF THE PANCREAS. A BUDGET IMPACT ANALYSIS IN GREECE
Aug 11, 2026, 17:16 PM -
PREVALENCE OF POTENTIALLY INAPPROPRIATE PRESCRIBING (PIP) IN OLDER ADULTS IN 2025 IN THE UNITED STATES: CAN WE DO BETTER IN THE DIGITAL AGE?
Aug 11, 2026, 17:16 PM -
INCORPORATING RISK PREFERENCES INTO VALUE ASSESSMENT FOR ALZHEIMER'S DISEASE: A DISCRETE CHOICE EXPERIMENT USING THE GRACE FRAMEWORK
Aug 11, 2026, 17:16 PM -
SHIFTING PATTERNS IN HEALTHCARE UTILIZATION IN TURKIYE: AN ANALYSIS OF HOSPITAL ADMISSION TRENDS UTILIZING SOCIAL SECURITY INSTITUTION (SGK) DATA (2022-2025)
Aug 11, 2026, 17:16 PM -
COST OF ACUTE ISCHAEMIC STROKE IN TURKIYE FROM THE SOCIAL HEALTH ORGANIZATION'S PERSPECTIVE
Aug 11, 2026, 17:16 PM -
PREVALENCE OF DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES (DEES) AMONG PATIENTS WITH EPILEPSY: A US CLAIMS ANALYSIS
Aug 11, 2026, 17:16 PM -
VALUE-TO-ACCESS (V2A): AN HTA FRAMEWORK FOR AI-ENABLED PRECISION MEDICINE
Aug 11, 2026, 17:16 PM -
ECONOMIC VALUE OF SUBCUTANEOUS VERSUS INTRAVENOUS LECANEMAB IN EARLY ALZHEIMER'S DISEASE: A COST-BENEFIT ANALYSIS FROM A SOCIETAL PERSPECTIVE IN JAPAN
Aug 11, 2026, 17:16 PM -
SYSTEMATIC LITERATURE REVIEW OF COST-EFFECTIVENESS, HEALTH-STATE UTILITY VALUES, AND HEALTHCARE COSTS AND RESOURCE USE EVIDENCE ASSOCIATED WITH SMALL CELL LUNG CANCER
Aug 11, 2026, 17:16 PM -
HTA METHODOLOGICAL ADAPTATIONS FOR RARE DISEASES AND ORPHAN DRUGS: A REVIEW OF GLOBAL FRAMEWORKS AND CONSIDERATIONS FOR LATIN AMERICA
Aug 11, 2026, 17:16 PM -
A HYBRID AI-ASSISTED SCREENING FRAMEWORK FOR SYSTEMATIC LITERATURE REVIEWS IN ACUTE ISCHAEMIC STROKE-LARGE VESSEL OCCLUSION: EFFICIENCY AND ACCURACY
Aug 11, 2026, 17:16 PM -
GOVERNMENT AND COMPULSORY HEALTH FINANCING AND HOUSEHOLD OUT-OF-POCKET PAYMENT IN CENTRAL AND EASTERN EUROPE: A COMPARATIVE ANALYSIS, 2014-2023
Aug 11, 2026, 17:16 PM -
DEVELOPMENT OF AN ONLINE EVIDENCE GENERATION SUPPORT TOOL FOR DIGITAL HEALTH TECHNOLOGY DEVELOPERS: PRELIMINARY RESULTS FROM THE ASSESS DHT PROJECT
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATION OF CYP3A5 GENOTYPE-GUIDED TACROLIMUS DOSING IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: A MONTE CARLO SIMULATION FROM AN INDIAN HEALTHCARE PERSPECTIVE
Aug 11, 2026, 17:16 PM -
BRIDGING THE GAP FROM SURROGATE TO HARD OUTCOMES IN C3 GLOMERULOPATHY: A BAYESIAN SURVIVAL MODELING FRAMEWORK TO PREDICT THE LONG-TERM IMPACT OF IPTACOPAN ON END-STAGE RENAL DISEASE (ESRD) FREE SURVIVAL
Aug 11, 2026, 17:16 PM -
A POPULATION-BASED DATA LINKAGE APPROACH TO STUDY FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA: OVERCOMING DATA FRAGMENTATION
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF MALARIA PREVENTION STRATEGIES IN CHILDREN UNDER FIVE IN HIGH-ENDEMIC SETTINGS
Aug 11, 2026, 17:16 PM -
REAL-WORLD EVIDENCE ON ORAL CLADRIBINE IN MULTIPLE SCLEROSIS: CLINICAL EFFECTIVENESS, TREATMENT PATTERNS AND ECONOMIC BURDEN
Aug 11, 2026, 17:16 PM -
ADVANCING THE ASSESSMENT OF DIGITAL HEALTH INNOVATION - LESSONS DRAWN FROM A CATALOGUE OF AI USE CASES
Aug 11, 2026, 17:16 PM -
COMPARING THE PSYCHOMETRIC PERFORMANCE OF FOUR FATIGUE-RELATED EQ-5D-5L BOLT-ONS IN A MULTINATIONAL, LONGITUDINAL GENERAL POPULATION SETTING
Aug 11, 2026, 17:16 PM
